SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.

Strachan, DP; Rutter, CE; Asher, MI; Bissell, K; Chiang, C-Y; El Sony, A; Ellwood, E; Ellwood, P; García-Marcos, L; Marks, GB; et al. Strachan, DP; Rutter, CE; Asher, MI; Bissell, K; Chiang, C-Y; El Sony, A; Ellwood, E; Ellwood, P; García-Marcos, L; Marks, GB; Morales, E; Mortimer, K; Pearce, N; Pérez-Fernández, V; Robertson, S; Silverwood, RJ; Global Asthma Network Phase I Study Group (2021) Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I. Pediatr Allergy Immunol, 33 (1). e13656. ISSN 1399-3038 https://doi.org/10.1111/pai.13656
SGUL Authors: Strachan, David Peter

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (403kB) | Preview
[img] Microsoft Excel (Supplementary information) Published Version
Available under License Creative Commons Attribution.

Download (1MB)
[img] Microsoft Word (.docx) (Appendix) Published Version
Available under License Creative Commons Attribution.

Download (22kB)
[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution.

Download (1MB)
[img] Microsoft Excel (Supplement) Accepted Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

BACKGROUND: The Global Asthma Network (GAN), by using the International Study of Asthma and Allergies in Childhood (ISAAC) methodology, has updated trends in prevalence of symptoms of childhood allergic diseases, including non-infective rhinitis and conjunctivitis ("rhinoconjunctivitis") which is reported here. METHODS: Prevalence and severity of rhinoconjunctivitis were assessed by questionnaire among schoolchildren in GAN Phase I and ISAAC Phases I and III surveys 15-23 years apart. Absolute rates of change in prevalence were estimated for each centre and modelled by multi-level linear regression to compare trends by age group, time period and per-capita national income. RESULTS: 27 GAN centres in 14 countries surveyed 74,361 13-14-year-olds ("adolescents") and 45,434 6-7-year-olds ("children"), with average response proportions of 90% and 79% respectively. Many centres showed highly significant (p<0.001) changes in prevalence of rhinoconjunctivitis in the past year ("current rhinoconjunctivitis"), compared to ISAAC. The direction and magnitude of centre-level trends varied significantly (p<0.001) both within and between countries. Overall, current rhinoconjunctivitis prevalence decreased slightly from ISAAC Phase III to GAN: -1.32% per 10 years, 95%CI [-2.93%, +0.30%] among adolescents; -0.44% [-1.29%, +0.42%] among children. Together, these differed significantly (p<0.001) from the upward trend within ISAAC. Among adolescents, centre-level trends in current rhinoconjunctivitis were highly correlated with those for eczema symptoms (rho=0.72, p<0.0001) but not with centre-level trends in asthma symptoms (rho=0.15, p=0.48). Among children, these correlations were positive but not significant. CONCLUSION: Symptoms of non-infective rhinoconjunctivitis among schoolchildren may no longer be on the increase globally, although trends vary substantially within and between countries.

Item Type: Article
Additional Information: © 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Prevalence, allergic disease, conjunctivitis, rhinitis, time trend, Global Asthma Network Phase I Study Group, 1107 Immunology, 1114 Paediatrics and Reproductive Medicine, Allergy
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: Pediatr Allergy Immunol
ISSN: 1399-3038
Language: eng
Dates:
DateEvent
31 December 2021Published
21 September 2021Published Online
19 August 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/N013638/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 34453861
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113560
Publisher's version: https://doi.org/10.1111/pai.13656

Actions (login required)

Edit Item Edit Item